Index of artpub/2023/319575/

Hirschfield, Gideon M
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis : ENHANCE, a phase 3, randomized, placebo-controlled study
2023
https://ddd.uab.cat/record/319575